Efficacy on the risk of vertebral fracture with administration of once-weekly 17.5 mg risedronate in Japanese patients of established osteoporosis with prevalent vertebral fractures: a 156-week longitudinal observational study in daily practice
Crossref DOI link: https://doi.org/10.1007/s00774-016-0771-x
Published Online: 2016-08-26
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Soen, Satoshi
Umemura, Takashi
Ando, Tsuyoshi
Kamisaki, Toshiaki
Nishikawa, Masahiko
Muraoka, Ryoichi
Ikeda, Yoshinori
Takeda, Kyoko
Osawa, Mitsuharu
Nakamura, Toshitaka
License valid from 2016-08-26